Sientra (NASDAQ:SIEN) issued its quarterly earnings results on Tuesday. The medical instruments supplier reported ($0.92) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.71) by ($0.21), Briefing.com reports. The company had revenue of $11.10 million for the quarter, compared to analyst estimates of $11.90 million. Sientra had a negative return on equity of 68.82% and a negative net margin of 169.77%. The firm’s quarterly revenue was up 70.8% on a year-over-year basis. During the same quarter last year, the company earned ($0.43) EPS.
Sientra (NASDAQ SIEN) opened at $10.03 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.87 and a quick ratio of 1.92. Sientra has a 52-week low of $7.20 and a 52-week high of $16.68.
A hedge fund recently bought a new stake in Sientra stock. State Street Corp bought a new stake in shares of Sientra Inc (NASDAQ:SIEN) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 149,072 shares of the medical instruments supplier’s stock, valued at approximately $1,449,000. State Street Corp owned 0.78% of Sientra at the end of the most recent quarter. 78.33% of the stock is owned by institutional investors.
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra and related companies with MarketBeat.com's FREE daily email newsletter.